Jim Cramer called Nuvation Bio (NUVB) a “pure spec” on Mad Money as the biopharma stock surges on an FDA win. Here’s what it ...
Jim Cramer said Thursday that "something's wrong" at Costco, and he plans to get to the bottom of it one way or another.
On the Aug. 31 episode of “Mad Money,” Jim Cramer argued that the August rallies in Palantir and Salesforce reflected a ...
Earlier this week, Morgan Stanley upgraded Robinhood to Overweight and raised its price target from $124 to $150. Bernstein ...
Mad Money' host Jim Cramer takes a closer look at Five Below after the stock reported earnings. Got a confidential news tip?
During the September 3 episode of Mad Money, host Jim Cramer said Meta Platforms, Inc. (NASDAQ:META) had become “a hated ...
Jim Cramer wants NVIDIA Corporation (NASDAQ:NVDA) to authorize a $500 billion buyback and purchase shares daily. His 1 Mad ...
Jim Cramer just called a stock he says matters more than Nvidia right now, and the pick is not who most AI investors are ...
Jim Cramer is calling the Magnificent Seven a generational buying opportunity, but the argument only holds for some of them, ...
FinanceBuzz on MSN
Jim Cramer says the AI trade isn't dead - here are the stocks proving it
MongoDB fell 13% despite beating estimates at 52x earnings. Dell rallied 16% at 16x after record revenue. Jim Cramer says the ...
24/7 Wall St. on MSNOpinion
“I saw the movie. I don’t want the sequel.” Jim Cramer warns Nvidia’s latest $250 billion deal is how companies died in the dot-com bubble
Quick ReadCramer warns $NVDA's $250 billion OpenAI financing guarantee mirrors the vendor lending deals that erased telecom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results